Efficacy and Safety clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • PRV-3279-2a Trial in Systemic Lupus

    open to eligible people ages 18-70

    The PREVAIL-2 study is designed to assess the safety and potential efficacy of PRV-3279 in flare prevention in systemic lupus erythematosus (SLE) patients with active disease after amelioration induced by corticosteroid treatment.

    at UCLA

Last updated: